<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The goal of the current work is to study the molecular mechanisms underlay the action of 5- amino-exo-3-azatricyclo[5.2.1.0(2,6)]decan-4-one (P-11) with combined antiarrhythmic, nootropic, anti-inflammatory and <z:chebi fb="164" ids="38867">anaesthetic</z:chebi> activities </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:chebi fb="0" ids="2430">aconitine</z:chebi>-induced experimental rat model of <z:hpo ids='HP_0011675'>cardiac arrhythmia</z:hpo> has been used in our study </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="2430">Aconitine</z:chebi> was administered once intravenously in a dose 50 microg/kg whereas experimental animal group received P-11 in a dose 0.3 mg/kg (the compound was injected intravenously 2 min before <z:hpo ids='HP_0011009'>acute</z:hpo> <z:chebi fb="0" ids="2430">aconitine</z:chebi> treatment) </plain></SENT>
<SENT sid="3" pm="."><plain>Expression macroarray (Atlas Rat cDNA Expression Array, #7738-1; BD Biosciences) was used to identify the target genes for P-11 compound </plain></SENT>
<SENT sid="4" pm="."><plain>Comparative analysis of changes in the status of expression of genes in the heart of rats induced by P-11 against the simulated in vivo <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> identified 16 genes that reproducibly alter the level of expression.These genes encode the extracellular matrix proteins (glypican 1, Gpc1; tissue inhibitor of metalloproteinase 2, 3, Timp2, Timp 3); intracellular signaling molecules (rho GTPase activating protein 7, Dlc1; protein tyrosine phosphatase 4a1, Ptp4a1; phosphodiesterase 4D, PDE4D; PI3-kinase regulatory subunit alpha, PIK3R1; <z:chebi fb="1" ids="16235">guanine</z:chebi> nucleotide binding protein alpha 12, Gna12) and protein of intermediate junctions (junction plakoglobin, Jup), proteins involved in glycolysis (phosphofructokinase I, Pfk1) and hemostasis (tissue plasminogen activator, Plat), plasma membrane transporters (Solute carrier family 16, member 1, Slc16a1; ATPase, <z:chebi fb="1" ids="29101">Na+</z:chebi>/K+ transporting, Atp1a), and ets </plain></SENT>
<SENT sid="5" pm="."><plain>(c-fos protooncogene, c-fos; telomerase protein component 1, tlp; Annexin 1, anxa 1) </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, the data about the selective effect of P-11 on genes whose products are involved in the aritmogenesys mechanisms, allow us to consider this compound as a promising means of pathogenetically oriented pharmacotherapy of <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> </plain></SENT>
</text></document>